منابع مشابه
Shingles and Shingles Vaccination
Shingles is caused by the human herpesvirus-3 (HHV-3). Primary infection usually occurs in childhood, producing chickenpox (varicella) although it can be subclinical. After this the virus lies dormant in the sensory nervous system in the geniculate, trigeminal or dorsal root ganglia. It may lie dormant for many years or many decades, kept in check by the immune system before flaring up in a sin...
متن کاملRe: secular trends in the epidemiology of shingles in Alberta.
Varicella vaccine was licensed in Canada in 1998, and a publicly funded vaccination programme introduced in the province of Alberta in 2001. In theory the vaccination programme might increase the burden of disease from shingles, making it important to develop baseline data against which future comparisons can be made. The study's aim was to describe the epidemiology of non-fatal cases of shingl...
متن کاملChickenpox and shingles infection
www.pjonline.com For personal use only. Not to be reproduced without permission of the editor ([email protected]) Coinuing prossional deelopm nt Identify knowledge gaps 1. What are the possible complications of chickenpox? 2. What should a pregnant woman with no history of chickenpox do if she comes into contact with the varicella zoster virus? 3. What is postherpetic neuralgia and how ...
متن کاملAsphalt Shingles
This chapter describes the methodology used in EPA’s Waste Reduction Model (WARM) to estimate streamlined life‐cycle greenhouse gas (GHG) emission factors for asphalt shingles beginning at the waste generation reference point. The WARM GHG emission factors are used to compare the net emissions associated with asphalt shingles in the following four waste management alternatives: source reduction...
متن کاملPractice of Epidemiology Long-TermEffectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study
A live attenuated zoster vaccine was licensed in the United States in 2006 for prevention of shingles in persons aged 60 years or older; the indication was extended in 2011 to cover those aged 50–59 years. We assessed vaccine effectiveness (VE) against shingles for 8 years after immunization at Kaiser Permanente Northern California. VEwas estimated by Cox regression with a calendar timeline tha...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Royal Society of Medicine
سال: 1991
ISSN: 0141-0768,1758-1095
DOI: 10.1177/014107689108400342